Search

Elli Peselev

Examiner (ID: 3791)

Most Active Art Unit
1623
Art Unit(s)
1203, 2899, 1621, 1623, 1803, 1673, 1802, 1211
Total Applications
2819
Issued Applications
1829
Pending Applications
143
Abandoned Applications
853

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7061689 [patent_doc_number] => 20050004051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Methods for treatment of bacterial infections in impaired renal patients' [patent_app_type] => utility [patent_app_number] => 10/860723 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32434 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004051.pdf [firstpage_image] =>[orig_patent_app_number] => 10860723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860723
Methods for treatment of bacterial infections in impaired renal patients Jun 1, 2004 Abandoned
Array ( [id] => 5242864 [patent_doc_number] => 20070021359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Addition salts of azithromycin and citric acid and process for preparing them' [patent_app_type] => utility [patent_app_number] => 10/558801 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 2370 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021359.pdf [firstpage_image] =>[orig_patent_app_number] => 10558801 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558801
Addition salts of azithromycin and citric acid and process for preparing them May 25, 2004 Abandoned
Array ( [id] => 7200060 [patent_doc_number] => 20050164958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'O-alkyl macrolide and azalide derivatives and regioselective process for their preparation' [patent_app_type] => utility [patent_app_number] => 10/851768 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5064 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164958.pdf [firstpage_image] =>[orig_patent_app_number] => 10851768 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851768
O-alkyl macrolide and azalide derivatives and regioselective process for their preparation May 20, 2004 Issued
Array ( [id] => 7122887 [patent_doc_number] => 20050014716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Pancreatic cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/850936 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5905 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014716.pdf [firstpage_image] =>[orig_patent_app_number] => 10850936 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850936
Pancreatic cancer treatment May 19, 2004 Abandoned
Array ( [id] => 7276311 [patent_doc_number] => 20040235762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Rapamycin carbohydrate derivatives' [patent_app_type] => new [patent_app_number] => 10/845747 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13924 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235762.pdf [firstpage_image] =>[orig_patent_app_number] => 10845747 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845747
Rapamycin carbohydrate derivatives May 12, 2004 Issued
Array ( [id] => 5107666 [patent_doc_number] => 20070066544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => '3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a' [patent_app_type] => utility [patent_app_number] => 10/557025 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14621 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066544.pdf [firstpage_image] =>[orig_patent_app_number] => 10557025 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557025
3-Decladinosyl 9a-n-carbamoyl and 9a-n-thiocarbamoyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a May 10, 2004 Abandoned
Array ( [id] => 5119562 [patent_doc_number] => 20070141276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Novel 14 and 15 membered ring compounds' [patent_app_type] => utility [patent_app_number] => 10/556706 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18931 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141276.pdf [firstpage_image] =>[orig_patent_app_number] => 10556706 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556706
Novel 14 and 15 membered ring compounds May 10, 2004 Abandoned
Array ( [id] => 5259651 [patent_doc_number] => 20070213283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Macrolides substituted at the 4\"-position' [patent_app_type] => utility [patent_app_number] => 10/556381 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34539 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213283.pdf [firstpage_image] =>[orig_patent_app_number] => 10556381 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556381
Macrolides substituted at the 4"-position May 10, 2004 Abandoned
Array ( [id] => 263785 [patent_doc_number] => 07569550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => '14 and 15 membered ring compounds' [patent_app_type] => utility [patent_app_number] => 10/556645 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28336 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569550.pdf [firstpage_image] =>[orig_patent_app_number] => 10556645 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556645
14 and 15 membered ring compounds May 10, 2004 Issued
Array ( [id] => 5231364 [patent_doc_number] => 20070293472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Novel 14 and 15 Membered Ring Compounds' [patent_app_type] => utility [patent_app_number] => 10/556708 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24306 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293472.pdf [firstpage_image] =>[orig_patent_app_number] => 10556708 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556708
Novel 14 and 15 Membered Ring Compounds May 10, 2004 Abandoned
Array ( [id] => 7122878 [patent_doc_number] => 20050014707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => '6,11-4C-bicyclic 9a-azalide derivatives' [patent_app_type] => utility [patent_app_number] => 10/840949 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23555 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014707.pdf [firstpage_image] =>[orig_patent_app_number] => 10840949 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/840949
6,11-4C-bicyclic 9a-azalide derivatives May 6, 2004 Abandoned
Array ( [id] => 720558 [patent_doc_number] => 07049417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => '6,11-4-Carbon bridged ketolides' [patent_app_type] => utility [patent_app_number] => 10/841206 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19528 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049417.pdf [firstpage_image] =>[orig_patent_app_number] => 10841206 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841206
6,11-4-Carbon bridged ketolides May 6, 2004 Issued
Array ( [id] => 7089650 [patent_doc_number] => 20050009763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => '6,11-4-Carbon bridged erythromycin derivatives' [patent_app_type] => utility [patent_app_number] => 10/841249 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19509 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009763.pdf [firstpage_image] =>[orig_patent_app_number] => 10841249 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841249
6,11-4-Carbon bridged erythromycin derivatives May 6, 2004 Abandoned
Array ( [id] => 7432515 [patent_doc_number] => 20040209827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => '11-C-substituted derivatives of clarithromycin' [patent_app_type] => new [patent_app_number] => 10/840986 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16928 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209827.pdf [firstpage_image] =>[orig_patent_app_number] => 10840986 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/840986
11-C-substituted derivatives of clarithromycin May 6, 2004 Abandoned
Array ( [id] => 8968190 [patent_doc_number] => 08507000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Controlled release formulation of erythromycin derivatives' [patent_app_type] => utility [patent_app_number] => 10/555849 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8259 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10555849 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555849
Controlled release formulation of erythromycin derivatives May 5, 2004 Issued
Array ( [id] => 7061688 [patent_doc_number] => 20050004050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Dalbavancin compositions for treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 10/834395 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32479 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004050.pdf [firstpage_image] =>[orig_patent_app_number] => 10834395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834395
Dalbavancin compositions for treatment of bacterial infections Apr 26, 2004 Issued
Array ( [id] => 7206048 [patent_doc_number] => 20050043223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility' [patent_app_type] => utility [patent_app_number] => 10/832965 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9619 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043223.pdf [firstpage_image] =>[orig_patent_app_number] => 10832965 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/832965
Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility Apr 25, 2004 Abandoned
Array ( [id] => 907286 [patent_doc_number] => 07332476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Pyridyl substituted ketolide antibiotics' [patent_app_type] => utility [patent_app_number] => 10/831749 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78173 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332476.pdf [firstpage_image] =>[orig_patent_app_number] => 10831749 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831749
Pyridyl substituted ketolide antibiotics Apr 22, 2004 Issued
Array ( [id] => 6983835 [patent_doc_number] => 20050153905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Novel ketolide derivatives' [patent_app_type] => utility [patent_app_number] => 10/831522 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19910 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153905.pdf [firstpage_image] =>[orig_patent_app_number] => 10831522 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831522
Ketolide derivatives Apr 22, 2004 Issued
Array ( [id] => 7318898 [patent_doc_number] => 20040224908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Stable compositions of dalbavancin' [patent_app_type] => new [patent_app_number] => 10/829068 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23222 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224908.pdf [firstpage_image] =>[orig_patent_app_number] => 10829068 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/829068
Stable compositions of dalbavancin Apr 19, 2004 Abandoned
Menu